| Dr Martin Stuart Zand, MD, PHD | |
|
601 Elmwood Ave, Box 675, Rochester, NY 14642-0001 | |
| (585) 275-4517 | |
| (585) 442-9201 |
| Full Name | Dr Martin Stuart Zand |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 32 Years |
| Location | 601 Elmwood Ave, Rochester, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326020249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 209991 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Strong Memorial Hospital | Rochester, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Strong Renal Group | 7315851672 | 44 |
News Archive
The peripheral nervous system is a vast network of nerves that exists primarily outside of brain and spinal cord and connects to the far reaches of the body. The very expanse of peripheral nerves makes them highly vulnerable to injuries such as blunt-force blows, cuts, and leg and arm fractures, as well as diseases that attack peripheral nerves such as diabetes, Charcot-Marie-Tooth, and Guillain-Barre syndrome.
The Christian Science Monitor reports on four key issues - a public option, raising taxes and cutting costs, individual mandates and abortion - that may become points of major differences when expected debate begins Nov. 30 on the Senate bill. The Monitor examines how each issue is covered in both the House and the Senate bills (Chaddock, 11/24).
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three months ended March 31, 2010. For the first quarter of 2010, the Company reported a net loss of $5.6 million or $0.16 per share, compared with a net loss of $6.7 million or $0.25 per share for the first quarter of 2009. Cash, cash equivalents and marketable securities as of March 31, 2010 were $25.0 million, up $15.3 million compared with December 31, 2009.
Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene - that is, one with the potential to cause a normal cell to become cancerous - but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.
› Verified 7 days ago
| Entity Name | Strong Renal Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881641470 PECOS PAC ID: 7315851672 Enrollment ID: O20031119000537 |
News Archive
The peripheral nervous system is a vast network of nerves that exists primarily outside of brain and spinal cord and connects to the far reaches of the body. The very expanse of peripheral nerves makes them highly vulnerable to injuries such as blunt-force blows, cuts, and leg and arm fractures, as well as diseases that attack peripheral nerves such as diabetes, Charcot-Marie-Tooth, and Guillain-Barre syndrome.
The Christian Science Monitor reports on four key issues - a public option, raising taxes and cutting costs, individual mandates and abortion - that may become points of major differences when expected debate begins Nov. 30 on the Senate bill. The Monitor examines how each issue is covered in both the House and the Senate bills (Chaddock, 11/24).
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three months ended March 31, 2010. For the first quarter of 2010, the Company reported a net loss of $5.6 million or $0.16 per share, compared with a net loss of $6.7 million or $0.25 per share for the first quarter of 2009. Cash, cash equivalents and marketable securities as of March 31, 2010 were $25.0 million, up $15.3 million compared with December 31, 2009.
Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene - that is, one with the potential to cause a normal cell to become cancerous - but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martin Stuart Zand, MD, PHD 601 Elmwood Ave, Box 675, Rochester, NY 14642-0001 Ph: (585) 275-7753 | Dr Martin Stuart Zand, MD, PHD 601 Elmwood Ave, Box 675, Rochester, NY 14642-0001 Ph: (585) 275-4517 |
News Archive
The peripheral nervous system is a vast network of nerves that exists primarily outside of brain and spinal cord and connects to the far reaches of the body. The very expanse of peripheral nerves makes them highly vulnerable to injuries such as blunt-force blows, cuts, and leg and arm fractures, as well as diseases that attack peripheral nerves such as diabetes, Charcot-Marie-Tooth, and Guillain-Barre syndrome.
The Christian Science Monitor reports on four key issues - a public option, raising taxes and cutting costs, individual mandates and abortion - that may become points of major differences when expected debate begins Nov. 30 on the Senate bill. The Monitor examines how each issue is covered in both the House and the Senate bills (Chaddock, 11/24).
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three months ended March 31, 2010. For the first quarter of 2010, the Company reported a net loss of $5.6 million or $0.16 per share, compared with a net loss of $6.7 million or $0.25 per share for the first quarter of 2009. Cash, cash equivalents and marketable securities as of March 31, 2010 were $25.0 million, up $15.3 million compared with December 31, 2009.
Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene - that is, one with the potential to cause a normal cell to become cancerous - but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.
› Verified 7 days ago
Amy Bodrog, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |